NCAM1 and chronic obstructive pulmonary disease: Our data also agrees with those of the Borchers laboratory [20] in showing no increase in NKG2D expression by lung cytotoxic lymphocytes in COPD, and significantly, we did not find a proportional increase in NK cells or CD56+ T cells in COPD, relative to smokers with preserved spirometry.